Transition Bio, Inc.
Biotechnology Research
Cambridge, Massachusetts, United States
26 employees
- Employees
- 26
Transition Bio, Inc. Overview
- Headquarters
- Cambridge, Massachusetts, United States
- Website
- www.transitionbio.com
- Industry
- Biotechnology Research
- Employees
- 26
- Funding
- 13.3M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Transition Bio, Inc.
Transition Bio is developing one-of-a-kind technologies for biomolecular condensate analysis. Through our Condensomics platform, our goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. We harness droplet microfluidic approaches and cellular platforms to characterize condensates with unprecedented scale and precision, resulting in the mapping of condensates and their modulation, in molecular detail. Our proprietary datasets feed in to algorithms that we use for target discovery, target validation and drug design.
Transition Bio, Inc. Contact Details
- People in AeroLeads
- 4
Transition Bio, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nagakumar Bharatham | Senior Principal Scientist @ Transition |
View
|
|
| Dan Jarosz | Associate Professor of Chemical | San Francisco Bay Area, United States |
View
|
| Kathy Yi | Boston, Massachusetts, United States |
View
|
|
| Samuel Cohen | Ride Therapeutics & Transition Bio |
View
|
Employees by Management Level
Senior / Lead
1 profile
Individual contributor
1 profile
Associate / junior
1 profile
Compare Similar Companies to Transition Bio, Inc.
Nona Biosciences
Biotechnology Research
Marengo Therapeutics
Biotechnology Research
Incendia Therapeutics
Biotechnology Research
Kytopen
Biotechnology Research
PhAST
Biotechnology Research
1910 Genetics
Biotechnology Research
Climb Bio
Biotechnology Research
QLD Biotherapeutics Inc
Biotechnology Research
Pledge Therapeutics
Biotechnology Research
Vivtex
Biotechnology Research